Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: Comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia

International Journal of Cardiovascular Imaging

Volumn 24, Issue 1, 2008, Pages 77-83

  Dimitrow, Paweł Petkow ^a   Klimeczek, Piotr ^b   Vliegenthart, Rozemarijn ^c   Pasowicz, Mieczysław ^b   Oudkerk, Matthijs ^c   Podolec, Piotr ^a   Tracz, Wiesława ^a   Dubiel, Jacek S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Hypertrophic cardiomyopathy; Magnetic resonance imaging

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTRAST HYPERENHANCEMENT; CONTROLLED STUDY; DEFIBRILLATOR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; RISK FACTOR; STATISTICAL SIGNIFICANCE; SUDDEN DEATH;

EID: 37249036060     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1007/s10554-007-9209-9     Document Type: Article

References (20)

1. Varnava AM, Elliott P, Sharma S et al (2000) Hypertrophic cardiomyopathy: The interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476-482
2. Shirani J, Pick R, Roberts WC et al (2000) Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden death. J Am Coll Cardiol 35:36-44
3. Varnava AM, Elliott P, Mahon N et al (2001) Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 88:275-279
4. Maron BJ, Savage DD, Wolfson JK et al (1981) Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy. Am J Cardiol 48:257
5. McKenna WJ, England D, Doi Y et al (1981) Arrhythmia in hypertrophic cardiomyopathy: 1. Influence on prognosis. Br Heart J 46:168-172
6. Monserrat L, Elliott P, Gimeno JR et al (2003) Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients. J Am Coll Cardiol 42:873-879
7. Elliott PM, Poloniecki J, Dickie S et al (2000) Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 36:2212-2218
8. McKenna WJ, Sadoul N, Slade AK et al (1994) The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. Circulation 90:3115-3117
9. McKenna WJ, Behr R (2002) Hypertrophic cardiomyopathy: Managment, risk stratification and prevention of sudden death. Heart 87:169-176
10. Kim RJ, Judd R (2003) Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: In vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol 41:1568-1572
11. Moon JC, Reed E, Sheppard MN et al (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260-2261
12. Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156-2164
13. Moon JC, McKenna WJ, McCrohon JA et al (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1568-1572
14. Teraoka K, Hirano M, Ookubo H et al (2004) Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 22:155-161
15. Richardson P, McKenna WJ, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841-842
16. Maron BJ, Epstein SE (1979) Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 43:1242-1244
17. Papavassiliu T, Schnabel P, Schroder M, Borggrefe M (2005). CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J 26:2395
18. Cecchi F, Olivotto I, Montereggi A et al (1998) Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: Assessment in an unselected non-referral based patient population. Heart 79:331-336
19. Kofflard MJ, ten Cate FJ, van Domburg RT (2003) Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 41:987-993
20. Saumarez RC, Slade AK, Grace AA et al (1995) The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. Circulation 91:2762-2768